Peanut Allergy R&D Pipeline Analysis Report, H2-2018 - ResearchAndMarkets.com

September 25, 2018

DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Peanut Allergy R&D Pipeline Analysis Report, H2-2018” report has been added to ResearchAndMarkets.com’s offering.

The Peanut Allergy pipeline guide presents complete overview of drugs currently being developed for Peanut Allergy. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Peanut Allergy pipeline candidate.

Research and Development progress along with latest news related to each of the Peanut Allergy pipeline candidates is included.

Major companies participating in therapeutic development of Peanut Allergy are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.

Amid strong interest for cure of Peanut Allergy from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Peanut Allergy clinical and pre clinical products.

The report assists in identifying potential upcoming companies and drugs in Peanut Allergy pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Key Topics Covered:

I. Key Findings

1. Companies Investing in Peanut Allergy Pipeline include

2. Pipeline Candidates

II. Insights into Peanut Allergy Pipeline

1. Disease Overview2. Phase wise Pipeline Compounds3. Company wise Peanut Allergy Pipeline Compounds

4. Peanut Allergy Pipeline by Mechanism of Action

III. Peanut Allergy Pipeline Compound Details

1. Snapshot

2. Drug Overview

3. Mechanism of Action4. Current Status5. Clinical Trial Details

IV. Peanut Allergy Pipeline Company Briefs

V. Latest News and Developments in Global Peanut Allergy Pipeline Market

VI. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/2crnbc/peanut_allergy?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005621/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Allergy Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/25/2018 08:07 AM/DISC: 09/25/2018 08:07 AM


Update hourly